TCON Tracon Pharmaceuticals Inc

TRACON Pharmaceuticals Inc is a clinical stage biopharmaceutical company. The Company is engaged in the development and commercialization of novel targeted therapeutics for cancer, age-related macular degeneration and fibrotic diseases.

$6.17
As of 05/12/2021     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  01/30/2015
Outstanding shares:  15,501,964
Average volume:  152,577
Market cap:   $87,896,136
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    89237H209
ISIN:        US89237H2094
Sedol:      BG0WPF7

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   5.14
PS ratio:   0.00
Return on equity:   -66.43%
Net income %:   0.00%